Abiopharma

AGF Management Limited to Release Third Quarter 2025 Financial Results on September 24, 2025

Le 24 septembre 2025, La Société de Gestion AGF Limitée annoncera ses résultats financiers pour le troisième trimestre de 2025

AGF Reports August 2025 Assets Under Management and Fee-Earning Assets

AGF déclare le total de son actif géré et de ses actifs donnant droit à des commissions pour août 2025

Ramaswamy Vivek 🔴 sold 1.8M shares of Roivant Sciences Ltd. (ROIV) at $12.96 ($22.5M) Transaction Date: Sep 03, 2025 | Filing ID: 000007

New Form 3 - Sintx Technologies, Inc. Filed: 2025-09-05 AccNo: 0001493152-25-012751 Size: 5 KB

New Form SCHEDULE 13D/A - STRATA Skin Sciences, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085116 Size: 13 KB

New Form SCHEDULE 13G/A - UTAH MEDICAL PRODUCTS INC Filed: 2025-09-05 AccNo: 0001041062-25-000177 Size: 6 KB

Elsbernd Brian 🟡 adjusted position in 50.0K shares (2 derivative) of CATALYST PHARMACEUTICALS, INC. (CPRX) at $20.08 ($1.2M) Transaction Date: Sep 03, 2025 | Filing ID: 000318

Full Circle Lithium Announces Closing of C$4.5 Million Private Placement

Chijet Motor Company Inc. Announces Issuance of Ordinary Shares to Holders of Contingent Value Rights

Larson-Green Julie 🟢 acquired 4.6K shares of Health Catalyst, Inc. (HCAT) Transaction Date: Sep 01, 2025 | Filing ID: 006121

Gallagher Duncan 🟢 acquired 5.0K shares of Health Catalyst, Inc. (HCAT) Transaction Date: Sep 01, 2025 | Filing ID: 006120

New Form 424B5 - BRUKER CORP Filed: 2025-09-05 AccNo: 0001140361-25-034214 Size: 1 MB

New Form 424B5 - USBC, Inc. Filed: 2025-09-05 AccNo: 0001654954-25-010448 Size: 19 KB